CMND vs CNTN

Clearmind Medicine Inc. vs Canton Strategic Holdings, Inc. — Valuation Comparison 2026

CMND

Biotechnology
Clearmind Medicine Inc.
Quality
1.6
out of 10
Value Trap
Price
$2.45
Last close
Models
6/13
Active
VS

CNTN

Biotechnology
Canton Strategic Holdings, Inc.
Quality
3.5
out of 10
Value Trap
24
SAFE
Price
$3.11
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType CMND Fair ValueCMND Upside CNTN Fair ValueCNTN Upside
Bayesian DCF Intrinsic $0.65 -73.5% $1.15 -62.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.50 -4.7% $3.17 +2.0%
Dynamic NAV Asset-Based $2.75 +10.7% $2.82 -9.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for CMND vs CNTN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CMND vs CNTN — Which Stock Is More Undervalued?

CNTN scores higher with a 3.5/10 quality rating vs CMND's 1.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Clearmind Medicine Inc. (CMND) and Canton Strategic Holdings, Inc. (CNTN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CMND currently trades at $2.45 with a QOC of 1.6/10, while CNTN trades at $3.11 with a QOC of 3.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).